Genprex (GNPX) Trading Overview
Trading Performance: Genprex shares rose 3.4 % during the 24‑hour period ending 05:36 AM Central Europe on Thursday, 22 April 2026. The current trading price is approximately USD 2.05.
Market Capitalization and Volume:
Market capitalization: USD 1.7 million.
Shares available for trade: 820.4 k.
Trading volume in the last 24 hours: USD 498.4 k.
Historical Context: Since the end of the previous month, Genprex has declined 38.79 %.
200‑day simple moving average: USD 22.29.
52‑week high: USD 249.48 (recorded 23 October 2025).
52‑week low: USD 2.03 (recorded 20 October 2026).
Related Stock Movements (24‑Hour Period)
| Ticker | Current Price | % Change | Market Capitalization |
|---|---|---|---|
| Nexalin (NXL) | USD 2.03 | –9.32 % | USD 2 million |
| Aoti (AOTI.L) | GBX 130 | 0 % | GBX 184 million |
| Revelation Biosciences (REVB) | USD 3.6 | +14.16 % | USD 1.9 million |
| Oragenics (OGEN) | USD 0.41 | +2.38 % | USD 1.9 million |
| Kairos Pharma (KAPA) | USD 0.58 | +2.46 % | USD 1.9 million |
Company Profile
- Name: Genprex, Inc.
- Industry: Biotechnology
- Specialization: Development of immunogene therapies for cancer treatment, clinical research, gene therapies, and consulting services.
- Geographic Focus: United States
- Website: www.genprex.com
- Exchange Listing: Nasdaq
- IPO Date: 29 March 2018
